Oncolytics Biotech Operating Expenses 2011-2026 | ONCY

Annual Operating Expenses Oncolytics Biotech

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	11.5 M	13.3 M	12.5 M	9.56 M	7.24 M	6.21 M	15.3 M	13.9 M	18.8 M	23.9 M	36.7 M	23.2 M

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
36.7 M	6.21 M	16 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aquestive Therapeutics AQST	85.5 M	$ 4.16	1.46 %	$ 445 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 9.77	1.82 %	$ 632 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Burford Capital Limited BUR	106 M	$ 5.15	4.46 %	$ 793 M	Britain
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
BioNTech SE BNTX	512 M	$ 98.14	-5.13 %	$ 27.2 B	Germany
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.15	-1.36 %	$ 3.67 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Cerus Corporation CERS	149 M	$ 2.79	37.44 %	$ 532 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Caladrius Biosciences CLBS	23.4 M	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Cardiff Oncology CRDF	49.6 M	$ 1.72	-0.87 %	$ 115 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Innate Pharma S.A. IPHA	63 M	$ 1.49	3.12 %	$ 235 M	France
Dynavax Technologies Corporation DVAX	137 M	-	-	$ 2.02 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.93	-8.15 %	$ 4.82 M	Israel
Eiger BioPharmaceuticals EIGR	62.1 M	-	-9.21 %	$ 2.55 M	USA
Editas Medicine EDIT	201 M	$ 2.9	-3.48 %	$ 257 M	USA
Eloxx Pharmaceuticals ELOX	34.4 M	-	-5.68 %	$ 8.28 M	USA
Edesa Biotech EDSA	6.71 M	$ 17.81	-2.57 %	$ 56.9 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA